A recent series identified that overall, 34% of its metaplastic breast cancer patients had intermediate or high sTIL infiltration; interestingly, this series also found that intermediate or high sTILs, but not PD-L1 positivity, correlated with improved clinical outcomes15. This evidence concerns the gene CD274 and breast carcinoma.